glp-1 benefits and side effects The expanding of medicines As patients begin GLP-1 regimens,

Intest Res

F., Luque-Ramrez, M

Notable Studies: Efficacy and safety of liraglutide 3.0 mg in patients with overweight and obese with or without diabetes: a systematic review and meta-analysis Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis Also Known As: Victoza, Saxenda, Xultophy, NN2211, GTPL1133 Research Applications: Weight loss Metabolic syndrome PCOS Neuroprotection Risks: Nausea and gastrointestinal upset Injection site reactions Tachycardia Potentially pancreatitis and neoplasias FDA approval limited to T2D and overweight/obese patients Chemical Structure What is Liraglutide

Mean age was 63.6 years

Diabetes 63:33463358 Kooijman S, Wang Y, Parlevliet ET et al (2015) Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice